CME: Diagnosis and Management of Breast Cancer – Recent Updates

Assam Cancer Care Foundation and Tezpur Medical College and Hospital (TMCH), organised a CME on Diagnosis and Management of Breast Cancer – Recent Updates at the TMCH auditorium on January 05, 2022. Prof. (Dr) Karuna Hazarika, MD, DMRD Principal cum Chief Superintendent, TMCH, Dr Madhab Rajbongshi, Med Superintendent, TMCH, Dr Deepak Mishra, Director Lab Services, Tata Medical Centre, Kolkata, Dr (Col) Sajal Sen, Chief Operating Officer, ACCF, Dr. Venkata Pradeep Babu Koyyala, Sr. Consultant Medical Oncologist, ACCF and Dr. Sanjeev K Gupta, Sr Consultant Radiation Oncologist, ACCF along with faculty and post graduate students had participated in the daylong event. Various subjects like optimising management of cancer with precision radiotherapy; recent options in the management of metastatic breast cancer; molecular pathology: importance of IHC and molecular tests in breast cancer were discussed in the programme.

Speaking on the occasion, Prof (Dr) Karuna Hazarika, said, "the latest imaging technology and other diagnostic tools have helped diagnosis of cancer quite early and thus, cure rates are increasing globally."

Dr Venkata Pradeep stated that survival in metastatic breast cancer increased by 25% compared to 1980s with current medications. A recent study shows that the number of women who died from breast cancer dropped by about 40% in the past 25 years, which translates into more than 322,000 lives saved during that period.

Dr Sanjeev K Gupta said "Breast-conserving surgery plus radiotherapy is at least equivalent to mastectomy with respect to overall survival and may influence treatment decision making for patients with early breast cancer. Advanced Radiation techniques like IMRT & DIBH may minimize toxicity associated with Radiotherapy."

Dr Deepak Mishra from TMC Kolkata emphasised the need for using molecular biology in diagnosis of breast cancer, which helps treating doctors to do targeted therapy and improves the cure rate drastically.